The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Classification Challenge of Pediatric Spondylarthritis

The Classification Challenge of Pediatric Spondylarthritis

April 1, 2010 • By Robert A. Colbert, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Spondylarthritis (SpA) refers to a group of disorders with overlapping clinical features, estimated to affect between 0.5% and 2% of the population.1,2 Most often included in the SpA group are ankylosing spondylitis (AS), which constitutes about half of SpA, reactive arthritis, the arthritides associated with psoriasis and inflammatory bowel disease, and undifferentiated SpA. Although the majority of SpA starts in the third or fourth decade of life, a significant proportion of patients (10–20%) begin to experience symptoms during childhood. In pediatric rheumatology clinics, SpA accounts for up to 15–20% of the cases of inflammatory arthritis, with oligoarthritis, polyarthritis, and systemic juvenile arthritis accounting for the majority.

You Might Also Like
  • ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease
  • New Diagnostic Criteria for Axial Spondylarthritis
  • Inflammatory Spinal Disorders Common in IBD Patients
Explore This Issue
April 2010

The most severe and often most debilitating form of SpA, AS, involves the axial skeleton and causes inflammation in the sacroiliac joints, vertebral bodies and intervertebral discs, and facet joints. Structural remodeling results in pathological bone formation in the form of osteophytes and syndesmophytes. These structures bridge vertebral bodies, leading to reduced spinal mobility and eventual fusion. At its earliest stages, SpA is often undifferentiated (i.e., lacks defining clinical or radiographic features) and may not involve the spine. The lack of axial involvement and related symptoms such as inflammatory back pain is particularly notable in children, who instead have a greater tendency to develop enthesitis and arthritis in the hips and other large joints of the lower extremities.3

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Progression from undifferentiated SpA to AS is unpredictable in adults and children, and there is often a long lag period (8–11 years) between the onset of symptoms and a diagnosis of AS.4-6 Prompt recognition and management of early axial SpA, whether presenting in children or adults, is our best hope to alter the disease course and improve long-term outcomes. However, identifying those patients with undifferentiated SpA who are most likely to develop axial disease and AS, as well as appropriate pathways and targets for therapeutic intervention, remain important unmet needs in SpA.

Colored X-ray of the thoracic and lumbar spine in a patient suffering from ankylosing spondylitis.
Colored X-ray of the thoracic and lumbar spine in a patient suffering from ankylosing spondylitis.

The Classification of SpA

Recognizing SpA in children and distinguishing it from other forms of juvenile arthritis can be a challenge. Rosenberg and Petty recognized the need for specific classification criteria in the early 1980s and proposed the concept of the seronegative enthesopathy and arthropathy (SEA) syndrome. This syndrome has been defined as enthesitis with arthralgia or arthritis in children less than 17 years of age who also lack rheumatoid factor (RF) and antinuclear antibodies.7 The features of the SEA syndrome helped distinguish SpA from juvenile arthritis, classified at the time as juvenile rheumatoid or juvenile chronic arthritis, without relying on evidence of axial involvement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Spondyloarthritis Tagged With: Diagnostic Criteria, Juvenile idiopathic arthritis, Pathogenesis, Pediatric, Pediatric Spondyloarthritis, TreatmentIssue: April 2010

You Might Also Like:
  • ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease
  • New Diagnostic Criteria for Axial Spondylarthritis
  • Inflammatory Spinal Disorders Common in IBD Patients
  • EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)